PATIENT ALERT: Masks are now optional in our VOA offices. If you are immunocompromised or feeling ill, masking is strongly encouraged. CLICK HERE for more details.
CLICK HERE regarding the Change Healthcare update.

Clinical Research & Trials

USO 22090

AN OPEN-LABEL MULTICENTER PHASE 1b-2 STUDY OF ELACESTRANT IN COMBINATION WITH ABEMACICLIB IN WOMEN AND MEN WITH BRAIN METASTASIS FROM ESTROGEN RECEPTOR POSITIVE, HER-2 NEGATIVE BREAST CANCER (ELECTRA) (ELA-0121)

Disease Types: Breast Cancer Research

Available at:

Norfolk (Brock Cancer Center)

Treatment Options

Services

Support During Cancer

Cancers We Treat

Blood Cancers

Blood Disorders

Find a Provider Near You

Clinical Research & Trials

Listen to our podcast

USO 22090

AN OPEN-LABEL MULTICENTER PHASE 1b-2 STUDY OF ELACESTRANT IN COMBINATION WITH ABEMACICLIB IN WOMEN AND MEN WITH BRAIN METASTASIS FROM ESTROGEN RECEPTOR POSITIVE, HER-2 NEGATIVE BREAST CANCER (ELECTRA) (ELA-0121)